Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375672 · ClinicalTrials.gov registry record · Phase 2
Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer
A Phase 2 study, sponsored by Hoosier Cancer Research Network.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT02375672 is a Phase 2 study that has completed, run by Hoosier Cancer Research Network. The registered enrollment target is 30 participants.
The verdict
NCT02375672, a Phase 2 study, has completed, sponsored by Hoosier Cancer Research Network.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.
Interventions
- DRUG Pembrolizumab
- DRUG mFOLFOX6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-05-28 |
| Est. Completion | 2020-10-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02375672
The ClinicalTrials.gov registry entry for NCT02375672 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoosier Cancer Research Network, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pembrolizumab is the first listed.
NCT02375672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02375672 about?
NCT02375672 is a clinical study titled "Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer". This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.
What is the current status of trial NCT02375672?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2015-05-28. Estimated completion is 2020-10-08.
What interventions are being tested in trial NCT02375672?
The interventions under investigation include: Pembrolizumab (DRUG), mFOLFOX6 (DRUG).
Who is sponsoring clinical trial NCT02375672?
This trial is sponsored by Hoosier Cancer Research Network, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.